460 / 1542
Conventional or Hypofractionated High Dose
Intensity Modulated Radiotherapy for
Prostate Cancer (CHHiP) Trial Design
T1B – T3A N0 M0
Estimated risk of seminal vesicle
involvement
≤ 30%
PSA ≤ 30ng/ml
Randomisation
Group 1
74Gy / 37#
Group 2
60Gy / 20#
Group 3
57Gy / 19 #
Recruitment
>3000 patients